Home > Insider Trading > Filing (0001209191-16-090425)

Filing Details

Accession Number:: 0001209191-16-090425
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-01-07 19:41:14
Reporting Period:: 2016-01-05

Filing Date:: 2016-01-07
Accepted Time:: 2016-01-07 19:41:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142750	Amn Healthcare Services Inc	AHS	Services-Help Supply Services (7363)	061500476

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1320242	L Denise Jackson	12400 High Bluff Drive San Diego CA 92130	General Counsel / Sr. V.p.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-01-05	22,241	$0.00	65,369	No	4	A	Direct
Common Stock	Disposition	2016-01-05	8,333	$30.18	57,036	No	4	F	Direct
Common Stock	Disposition	2016-01-06	11,813	$29.22	45,223	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2016-01-05	4,639	$0.00	4,639	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,639			No	4	A	Direct

Footnotes

The acquisition of common stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2013. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2012 for the 3-year period beginning on January 1, 2013 and ended December 31, 2015 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 5, 2016. The Company's Relative TSR measured in the 92nd percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.
Number of shares withheld for tax purposes.
The sale of 11,813 shares of Common Stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 represents a weighted average price of $29.2167 per share. These shares were sold in multiple transactions at prices ranging from $28.70 to $29.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
The Restricted Stock Units were granted on January 5, 2016 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33% should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2016 fiscal year and on the second anniversary of the grant date in the amount of 34% should the Company achieve or exceed the specified EBITDA target for the 2017 fiscal year.
Restricted Stock Units do not have an expiration date.